Role of the thalamic intergeniculate leaflet and its 5-HT afferences in the chronobiological properties of 8-OH-DPAT and triazolam in Syrian hamster

Brain Research

Volumn 849, Issue 1-2, 1999, Pages 16-24

  Schuhler, Sandrine ^a   Pitrosky, Bruno ^a   Saboureau, Michel ^a   Lakhdar Ghazal, Nouria ^a,b   Pévet, Paul ^a  

^a CNRS   (France)

^b FACULTÉ DES SCIENCES   (Morocco)

Author keywords

Circadian rhythm; IGL; Neuropeptide Y; Non photic; Serotonin; Suprachiasmatic nucleus

Indexed keywords

2 DIPROPYLAMINO 8 HYDROXYTETRALIN; SEROTONIN; TRIAZOLAM;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CHRONOBIOLOGY; CIRCADIAN RHYTHM; CONTROLLED STUDY; IMMUNOHISTOCHEMISTRY; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; SEROTONINERGIC SYSTEM; SUPRACHIASMATIC NUCLEUS; SYRIAN HAMSTER; THALAMUS;

EID: 0032728871     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(99)01914-9     Document Type: Article

References (59)

1. Albers H.E., Ferris C.F. Neuropeptide Y: role in light-dark cycle entrainment of hamster circadian rhythm. Neurosci. Lett. 50:1984;163-168.
2. Albers H.E., Mintz E.M. Microinjection of neuropeptide-Y antisera into the suprachiasmatic (SCN) region blocks the phase shifting effects of systemic injections of 8-OH-DPAT. Soc. Neurosci. Abstr. 23:1997;512.
3. Baumgarten H.G., Jenner S., Klemm H.P. Serotonin neurotoxins: recent advances in the mode of administration and molecular mechanism of action. J. Physiol. 77:1981;309-314.
4. Belin M.F., Aguera M., Tappaz M., McRae-Degueurce A., Bobillier P., Pujol J.F. GABA-accumulating neurons in the nucleus raphe dorsalis and periaqueductal gray in the rat: a biochemical and radioautographic study. Brain Res. 170:1979;279-297.
5. Biello S.M., Janik D., Mrosovsky N. Neuropeptide Y and behaviorally induced phase shifts. Neuroscience. 62:1994;273-279.
6. Bina K.G., Rusak B., Semba K. Localization of cholinergic neurons in the forebrain and brainstem that project to the suprachiasmatic nucleus of the hypothalamus in rat. J. Comp. Neurol. 335:1993;295-307.
7. Bobrzynska K.J., Vrang N., Mrosovsky N. Persistence of nonphotic phase shifts in hamsters after serotonin depletion in the suprachiasmatic nucleus. Brain Res. 741:1996;205-214.
8. Bosler O., Beaudet A. VIP neurons as prime synaptic targets for serotonin afferents in rat suprachiasmatic nucleus: a combined radioautographic and immunocytochemical study. J. Neurocytol. 14:1985;749-776.
9. Bosler O. Ultrastructural relationships of serotonin and GABA terminals in the rat suprachiasmatic nucleus: evidence for a close interconnection between the two afferent systems. J. Neurocytol. 18:1989;105-113.
10. Buijs R.M., Pool C.W., Van Heerikhuize J.J., Sluiter A.A., Van der Sluis P.J., Ramkema M., Van der Woude T.P., Van der Beek E. Antibodies to small transmitter molecules and peptides: production and application of antibodies to dopamine, serotonin, GABA, vasopressin, vasoactive intestinal peptide, neuropeptide Y, somatostatin and substance P. Biomed. Res. 10:1989;213-221.
11. Challet E., Pévet P., Malan A. Lesion of the serotonergic terminals in the suprachiasmatic nuclei limits the phase advance of body temperature rhythm in food-restricted rats fed during daytime. J. Biol. Rhythms. 12:1997;235-244.
12. Challet E., Scarbrough K., Penev P., Turek F. Roles of suprachiasmatic nuclei and intergeniculate leaflets in mediating the phase-shifting effects of a serotonergic agonist and their photic modulation during subjective day. J. Biol. Rhythms. 13:1998;410-421.
13. 1A binding in rat brain - a combined in situ hybridization/in vitro receptor autoradiographic study. Brain Res. 561:1991;51-60.
14. Cutrera R.A., Kalsbeek A., Pévet P. No triazolam induced expression of Fos protein in raphe nuclei of the male Syrian hamster. Brain Res. 602:1993;14-20.
15. Cutrera R.A., Kalsbeek A., Pévet P. Specific destruction of the serotonergic afferents to the suprachiasmatic nuclei prevents triazolam induced phase-advances of hamster activity rhythms. Behav. Brain Res. 62:1994;21-28.
16. 1A receptor agonist 8-OH-DPAT and other non-photic stimuli on the circadian rhythm of wheel-running activity in hamsters under different constant conditions. Neurosci. Lett. 172:1994;27-30.
17. 7 receptor agonist, on locomotor activity in golden hamster in constant darkness. Neurosci. Lett. 210:1996;1-4.
18. Dark J., Asdourian D. Entrainment of the rat's activity rhythm by cyclic light following lateral geniculate nucleus lesions. Physiol. Behav. 15:1975;295-301.
19. Dudley T.E., DiNardo L.A., Glass D. Endogenous Regulation of serotonin release in the hamster suprachiasmatic nucleus. J. Neurosci. 18:1998;5045-5052.
20. Francois-Bellan A.M., Hery M., Faudon M., Hery F. Evidence for GABA control of serotonin metabolism in the rat suprachiasmatic area. Neurochem. Int. 13:1988;455-462.
21. Francois-Bellan A.M., Kachidian P., Dusticier G., Tonon M.C., Vaudry H., Bosler O. GABA neurons in the rat suprachiasmatic nucleus: involvement in chemospecific synaptic circuitry and evidence for GAD-peptide colocalisation. J. Neurocytol. 19:1990;937-947.
22. Francois-Bellan A.M., Bosler O. Convergent serotonin and GABA innervation of VIP neurons in the suprachiasmatic nucleus demonstrated by triple labeling in the rat. Brain Res. 595:1992;149-153.
23. Golombek D.A., Biello S.M., Rendon R.A., Harrington M.E. Neuropeptide Y phase shifts the circadian clock in vitro via Y2 receptor. NeuroReport. 7:1996;1315-1319.
24. Gribkoff V.K., Pieschl R.L., Wisialowski T.A., Van den Pol A.N., Yocca F.D. Phase shifting of circadian rhythms and depression of neuronal activity in the rat suprachiasmatic nucleus by neuropeptide Y: mediation by different receptor subtypes. J. Neurosci. 18:1998;3014-3022.
25. Guy J., Bosler O., Dusticier G., Pelletier G., Calas A. Morphological correlates of serotonin-neuropeptide Y interactions in the rat suprachiasmatic nucleus: combined radioautographic and immunocytochemical data. Cell Tissue Res. 250:1987;657-662.
26. Hisano S., Chikamori-Aoyama M., Katoh S., Kagotani Y., Daikoku S., Chihara K. Suprachiasmatic nucleus neurons immunoreactive for vasoactive intestinal polypeptide have synaptic contacts with axons immunoreactive for neuropeptide Y: an immunoelectron microscopic study in the rat. Neurosci. Lett. 88:1988;145-150.
27. 1A receptor agonist 8-OH-DPAT on the release of 5-HT in dorsal and median raphe-innervated rat brain regions as measured by in vivo microdialysis. Life Sci. 48:1991;1779-1786.
28. Huhman K.L., Albers H.E. Neuropeptide Y microinjected into the suprachiasmatic region phase shifts circadian rhythms in constant darkness. Peptides. 15:1994;1475-1478.
29. Huhman K.L., Babagbemi T.O., Albers H.E. Bicuculline blocks neuropeptide Y-induced phase advances when microinjected in the suprachiasmatic nucleus of Syrian hamsters. Brain Res. 675:1995;333-336.
30. 2 receptor. NeuroReport. 7:1996;1249-1252.
31. Janik D., Mrosovsky N. Intergeniculate leaflet lesions and behaviorally-induced shifts of circadian rhythms. Brain Res. 651:1994;174-182.
32. Johnson R.F., Smale L., Moore R.Y., Morin L.P. Lateral geniculate lesions block circadian phase-shift responses to a benzodiazepine. Proc. Natl. Acad. Sci. USA. 85:1988;5301-5304.
33. I.J. Kopin, Neurotoxins affecting biogenic aminergic neurons, in: H.Y. Meltzer (Ed.), Psychopharmacology: The Third Generation of Progress, Raven Press, New York, 1987, pp. 351-358.
34. D.C. Klein, R.Y. Moore, S.M. Reppert, (Eds.), Suprachiasmatic Nucleus. The Mind's Clock, 1st edn., Oxford Univ. Press, New York, 1991, 467 pp.
35. Mackay-Sim A., Sefton A.J., Martin P.R. Subcortical projections to lateral geniculate and thalamic reticular nuclei in the hooded rat. J. Comp. Neurol. 213:1983;24-35.
36. Marchant E.G., Watson N.V., Mistlberger R.E. Both neuropeptide Y and serotonin are necessary for entrainment of circadian rhythms in mice by daily treadmill running schedules. J. Neurosci. 17:1997;7974-7987.
37. Medanic M., Gillette M.U. Suprachiasmatic circadian pacemaker of rat shows two windows of sensitivity to neuropeptide Y in vitro. Brain Res. 620:1993;281-286.
38. Meyer E.L., Harrington M.E., Rahmani T. A phase-response curve to the benzodiazepine chlordiazepoxide and the effect of geniculo-hypothalamic tract ablation. Physiol. Behav. 53:1993;237-243.
39. Meyer-Bernstein E.L., Morin L. Differential serotonergic innervation of the suprachiasmatic nucleus and the intergeniculate leaflet and its role in circadian rhythm modulation. J. Neurosci. 16:1996;2097-2111.
40. Meyer-Bernstein E.L., Morin L. Destruction of serotonergic neurons in the median raphe nucleus blocks circadian rhythm phase shifts to triazolam but not to novel wheel access. J. Biol. Rhythms. 13:1998;494-505.
41. A-benzodiazepine receptor localization in the circadian timing system. Brain Res. 531:1990;16-24.
42. Mintz E.M., Gillespie C.F., Marvel C.L., Huhman K.L., Albers H.E. Serotonergic regulation of circadian rhythms in Syrian hamsters. Neuroscience. 79:1997;563-569.
43. Moore R.Y., Speh J.C. GABA is the principal neurotransmitter of the circadian system. Neurosci. Lett. 150:1993;112-116.
44. Moore R.Y., Card J.P. Intergeniculate leaflet: an anatomically and functionally distinct subdivision of the lateral geniculate complex. J. Comp. Neurol. 344:1994;403-430.
45. Morin L.P., Blanchard J. Organization of the hamster intergeniculate leaflet; NPY and ENK projections to the suprachiasmatic nucleus, intergeniculate leaflet and posterior limitans nucleus. Vis. Neurosci. 12:1995;57-67.
46. Mrosovsky N. Phase response curves for social entrainment. J. Comp. Physiol. A 162:1988;35-46.
47. Pasquier D.A., Villar M.J. Subcortical projections to the lateral geniculate body in the rat. Exp. Brain Res. 48:1982;409-419.
48. Pickard G.E., Ralph M.R., Menaker M. The intergeniculate leaflet partially mediates effects of light on circadian rhythms. J. Biol. Rhythms. 2:1987;35-56.
49. Prosser R.A., Dean R.R., Edgar D.M., Heller H.C., Miller J.D. Serotonin and the mammalian circadian system: I. In Vitro phase shifts by serotonergic agonists and antagonists. J. Biol. Rhythms. 8:1993;1-16.
50. Reebs S.G., Mrosovsky N. Effects of induced wheel running on the circadian activity rhythms of Syrian hamsters: entrainment and phase-response curve. J. Biol. Rhythms. 4:1989;39-48.
51. Sainati S.M., Lorens S.A. Intra-raphe benzodiazepines enhance rat locomotor activity: interactions with GABA. Pharmacol. Biochem. Behav. 18:1983;407-414.
52. Schuhler S., Saboureau M., Pitrosky B., Pévet P. In Syrian hamsters, 5-HT fibres within the suprachiasmatic nuclei are necessary for the expression of 8-OH-DPAT induced phase-advance of locomotor activity rhythm. Neurosci. Lett. 256:1998;33-36.
53. Shibata S., Moore R.Y. Neuropeptide Y and optic chiasm stimulation affect suprachiasmatic nucleus circadian function in vitro. Brain Res. 615:1993;95-100.
54. Smith R.D., Inouye S.I.T., Turek F.W. Central administration of muscimol phase-shifts the mammalian circadian clock. J. Comp. Physiol. 164:1989;805-814.
55. Stopa E.G., Johnson J.K., Friedman D.I., Ryer H.I., Reidy J., Kuo-LeBlanc V., Albers H.E. Neuropeptide Y receptor distribution and regulation in the suprachiasmatic nucleus of the Syrian hamster (Mesocricetus auratus). Peptide Res. 8:1995;95-100.
56. 1A receptor agonists on the circadian rhythm of wheel-running activity in hamsters. Eur. J. Pharmacol. 214:1992;79-84.
57. Turek F.W., Van Reeth O. Altering the mammalian circadian clock with the short-acting benzodiazepine triazolam. Trends Neurosci. 11:1988;535-541.
58. Wickland C., Turek F.W. Lesions of the thalamic intergeniculate leaflet block activity-induced phase shifts in the circadian activity rhythm of the golden hamster. Brain Res. 660:1994;293-300.
59. Yamada H., Mori S., Ueda S., Kawata M., Sano Y. Improvement of technique of immunohistochemical demonstration of bioactive substances in the central nervous system. Acta Histochem. Cytochem. 20:1987;629-637.